New Page 1

Henry A. Frazer, Pharm. D., CCTI
Founder and President
Email: hfrazer@drugresearch.com

EDUCATION
Doctor of Pharmacy (Pharm D) - Mercer University (1975)
Bachelor of Science, Pharmacy - University of Mississippi (1963 )

CERTIFICATIONS
Certified Clinical Investigator - CCI (2003)
Certified Clinical Trial Investigator - CCTI (2006)

LICENSES
State of Alabama (No. 6253)
State of Mississippi (No. E-3932)

EXPERIENCE
1978 - Present: Founder and President, Drug Research & Analysis Corp.
1968 - 1978: CRA, Associate Director of Clinical Pharmacology Hoesch-Roussel Pharmaceuticals, Inc.
1966 - 1968: U.S. Public Health Service, U.S. Food & Drug Administration Bureau of Medicine, Washington, D.C.
1963- 1966: Practice of Pharmacy

MILITARY SERVICE
1966 - 1968: U.S. Public Health Service, Honorable Discharge
1966: U.S. Army Reserve, Honorable Discharge

COMMUNITY SERVICE
Present: Deacon, Teacher, History and Development of Christianity First Baptist Church, Montgomery, AL
1994 - 1996 Board of Directors, Chairman, Montgomery Regional Medical Center
1988 - 1993 President, Central Alabama Community Foundation
1990 - 1991 President, Kiwanis Club of Montgomery
1986 - 1988 President, Landmarks Historic Foundation

HONORS/DISTINCTIONS
2007: "Distinguished Alumnus", University of Mississippi School of Pharmacy
2005: "Distinguished Alumnus" Hall of Fame, University of Mississippi
1995: "Masters of Progress" Hall of Fame, Sidney Lanier High School
1991: Nominee for "Liberty Bell" Award from Alabama Bar Association
1990: Nominee for "Bowl of Hygeia" award from A. H. Robins Pharm. Co.
1982: U.S. Clinical Pharmacology Delegation to People's Republic of China

EMPLOYMENT
November, 1978 - present: Founder and President of Drug Research and Analysis Corp. Montgomery, AL
Firm operates as a contract clinical research service to the pharmaceutical industry to support Investigational New Drug Applications submitted to the FDA. Since 1978 DRAC has conducted over 500 research trials in their on-site clinic and in other clinics and physicians' offices throughout the U.S. The FDA has approved over 60 New Drug Applications in this time based, in part, on DRAC's participation in and management of clinical trials. Dr. Frazer has been the principal investigator on approximately 30 research trials for a variety of indications such as HBP, arthritis, asthma, UTI, dysmenorrhea, AIDS, sinusitis, bronchitis, post operative surgical pain, ischemic strokes and Phase I pharmacokinetics. He has lectured for several pharmaceutical companies on the use of their drugs and for several pharmacy schools on opportunities and alternative vocations for pharmacists.

(Publications available upon request)